Trials / Completed
CompletedNCT04840953
Negative Pressure Therapy, Minimally Invasive and Accessible Technique in the Treatment of Massive Subcutaneous Emphysema in COVID-19 or Non Infected Critical Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2 (actual)
- Sponsor
- Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Background Numerous surgicals treatments have been described for the massive subcutaneous emphysema; however, some of these techniques cannot be carried out in a critical care unit and they are related with high morbidity and exposure in positive SARS COV-2 patients. More effective, less invasive and isolated procedures should be implemented. Technique Negative pressure therapy (NPT) that can allow effective solving of massive subcutaneous emphysema in a short period (5 days) with a minimally invasive approach at the bedside in Covid-19 or non infected critical patients. Conclusion NPT is an effective and low invasive strategy for the management of EES in critical patients with high risk of mortality.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Vçac | VAC THERAPY vs SURGICAL DREINAGE |
Timeline
- Start date
- 2020-12-01
- Primary completion
- 2021-01-01
- Completion
- 2021-02-01
- First posted
- 2021-04-12
- Last updated
- 2021-04-12
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT04840953. Inclusion in this directory is not an endorsement.